marzarolimd Profile Banner
Matteo Marzaroli Profile
Matteo Marzaroli

@marzarolimd

Followers
10
Following
40
Statuses
17

Anesthesiology and Intensive Care resident doctor @SanRaffaeleMI Follow @SRanesthesiaICU

Milan
Joined June 2023
Don't wanna be here? Send us removal request.
@marzarolimd
Matteo Marzaroli
1 year
RT @SRAnesthesiaICU: 7 new anesthesiologists graduated today in Milan @MyUniSR @SanRaffaeleMI 101 are queuing up @marzarolimd @Barbara58
0
9
0
@marzarolimd
Matteo Marzaroli
2 years
RT @SRAnesthesiaICU: 10/ It's our honor to publish the results of #MERCYtrial in JAMA @JAMA_current: Continuous vs Intermittent Meropenem…
0
15
0
@marzarolimd
Matteo Marzaroli
2 years
RT @SRAnesthesiaICU: We've just presented and published a multicenter RCT at #CCR23 and in @JAMA_current! Continuous vs Intermittent Merop…
0
142
0
@marzarolimd
Matteo Marzaroli
2 years
RT @JAMA_current: Editorial: "Monti and colleagues are to be commended for their well-designed and well-executed contribution to the contro…
0
11
0
@marzarolimd
Matteo Marzaroli
2 years
RT @JAMA_current: Continuous administration of meropenem, compared with intermittent administration, does not improve clinically relevant o…
0
115
0
@marzarolimd
Matteo Marzaroli
2 years
RT @YukiKotani5: It is my honor to work with the excellent team of this fantastic randomized clinical trial. Every piece I learned during t…
0
2
0
@marzarolimd
Matteo Marzaroli
2 years
RT @YukiKotani5: Primary outcome: a composite of mortality or new emergence of PDR/XDR bacteria at day 28 No significant difference in the…
0
1
0
@marzarolimd
Matteo Marzaroli
2 years
RT @YukiKotani5: Infographic of the trial design Both groups received an initial loading dose (1g of meropenem). Double-dummy administratio…
0
2
0
@marzarolimd
Matteo Marzaroli
2 years
RT @YukiKotani5: A previous meta-analysis of RCTs showed a decreased mortality when beta-lactams are administered continuously, but there a…
0
3
0
@marzarolimd
Matteo Marzaroli
2 years
RT @YukiKotani5: Time above MIC is an important determinant for beta-lactams, including meropenem. So, continuous infusion of meropenem is…
0
1
0
@marzarolimd
Matteo Marzaroli
2 years
Tweet media one
0
11
0
@marzarolimd
Matteo Marzaroli
2 years
RT @ABsteward: 🔥🆕️MERCY RCT🆕️🔥 Continuous administration of meropenem, compared with intermittent administration, does NOT improve clinica…
0
135
0
@marzarolimd
Matteo Marzaroli
2 years
RT @OrlandoRPN: Meropenem en infusión 🆚 intermitente en pacientes con Sepsis 💊 🦠 No hay diferencias en mortalidad 🟰
0
116
0
@marzarolimd
Matteo Marzaroli
2 years
RT @YukiKotani5: From 13:30 tomorrow (GMT), Prof. @GiacomoMonti & Prof. @giovannilandoni from @SRAnesthesiaICU will present #MERCYtrial res…
0
11
0
@marzarolimd
Matteo Marzaroli
2 years
RT @karimbrohi: UK-REBOA results: REBOA increased mortality at 90 days and at all interim time points. REBOA increased deaths due to blee…
0
473
0
@marzarolimd
Matteo Marzaroli
2 years
RT @NEJM: Late breaking at #CCR23: In the PATCH-Trauma trial involving adults with major trauma, treatment with tranexamic acid did not res…
0
177
0